Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Sep 26, 2014; 6(9): 890-907
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.890
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.890
Metabolic syndrome component | Goal of therapy | Drugs | Diet | Physical exercise |
Arterial hypertension | BP < 140/90 mmHg | ACEI or ARBs and/ or Ca-antagonists and/ or alpha-blockers1 Limit diuretics and beta-blockers | Salt restriction and hypocaloric | Regular exercise |
Hyperglycemia | HbA1c < 7%-6.5% | Metformin GLP-1-Agonists DPP-4-inhibitors | Hypocaloric | Regular exercise |
Obesity | Weight loss 7%-10% | Orlistat Bariatric Surgery | Hypocaloric | Regular exercise |
Dyslipidemia | LDL < 100-70 mg/dL TG < 150 mg/dL HDL: Men > 40/ Women > 50 mg/dL | Statins ± ezetimibe. PUFA-n-3, Fibrates | Hypocaloric | Regular exercise |
- Citation: Mulè G, Calcaterra I, Nardi E, Cerasola G, Cottone S. Metabolic syndrome in hypertensive patients: An unholy alliance. World J Cardiol 2014; 6(9): 890-907
- URL: https://www.wjgnet.com/1949-8462/full/v6/i9/890.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i9.890